# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 101-110 of 2722 results.
Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm
Status: Not yet recruiting
Last Changed: Oct 08, 2020
First Received: Jan 02, 2020
Disease(s): Ovarian Cancer
Intervention(s): Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients
Status: Terminated
Last Changed: Nov 24, 2011
First Received: Jan 05, 2007
Disease(s): Ovarian Cancer
Intervention(s): Abagovomab, Placebo
Locations: Cedars-Sinai Medical Center, Los Angeles, California, United States
University of California, Los Angeles (UCLA), Los Angeles, California, United States
Stanford University, Stanford, California, United States
University of Colorado, Denver, Colorado, United States
University of Connecticut Health Center, Farmington, Connecticut, United States
... and 146 other locations.
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)
Status: Recruiting
Last Changed: Oct 22, 2020
First Received: May 07, 2019
Disease(s): Ovarian Cancer
Intervention(s): NovoTTF-100L(O), Paclitaxel
Locations: Arizona Oncology, Tucson, Arizona, United States
California Pacific Medical Center- Pacific Campus, San Francisco, California, United States
Olive View - UCLA Medical Center, Sylmar, California, United States
Rocky Mountain Cancer Centers, Aurora, Colorado, United States
University of Colorado Denver, Aurora, Colorado, United States
... and 95 other locations.
Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer
Status: Recruiting
Last Changed: Jul 08, 2020
First Received: Jul 08, 2020
Disease(s): Ovarian Cancer
Intervention(s): Exemestane, Placebo oral tablet
Locations: AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, AL, Italy
Ospedale Oncologico IRCCS Bari, Bari, BA, Italy
Ospedale degli Infermi, Biella, BI, Italy
AULSS 1 Dolomiti - Ospedale "Santa Maria del Prato", Feltre, BL, Italy
Azienda Ospedaliero Universitaria Policlinico S.Orsola-Malpighi, Bologna, BO, Italy
... and 43 other locations.
Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2
Status: Completed
Last Changed: Jul 08, 2020
First Received: Jul 08, 2020
Disease(s): Ovarian Cancer
Intervention(s): 211-astatine MX35 F(ab')2
Locations: Sahlgrenska University Hospital, Dept of Oncology, Gothenburg, Sweden
Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients With Recurrent Ovarian Cancer
Status: Completed
Last Changed: Feb 18, 2015
First Received: Mar 21, 2013
Disease(s): Recurrent Epithelial Ovarian Cancer
Intervention(s): Catumaxomab
Locations: Charité Campus Virchow-Klinikum, Berlin, Germany
Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer
Status: Withdrawn
Last Changed: Nov 02, 2016
First Received: Feb 12, 2009
Disease(s): Ovarian Cancer
Intervention(s): Azacitidine, Azacitidine, Azacitidine
Locations: Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center, Maywood, Illinois, United States
Central Dupage Hospital, Winfield, Illinois, United States
China Ovarian Cancer BRCA Testing Study
Status: Terminated
Last Changed: Oct 14, 2020
First Received: Jun 29, 2017
Disease(s): Ovarian Cancer
Locations: Research Site, Hefei, Anhui, China
Research Site, Beijing, Beijing, China
Research Site, Beijing, Beijing, China
Research Site, Beijing, Beijing, China
Research Site, Chongqing, Chongqing, China
... and 15 other locations.
A Study of Niraparib in Patients With Relapsed Ovarian Cancer
Status: Not yet recruiting
Last Changed: May 18, 2020
First Received: May 18, 2020
Disease(s): Ovarian Cancer
Intervention(s): ZL-2306(Niraparib)
Open Label Immunotherapy Trial for Ovarian Cancer
Status: Recruiting
Last Changed: Aug 30, 2019
First Received: Jun 14, 2018
Disease(s): Ovarian Cancer
Intervention(s): Tableted vaccine (V3-OVA) containing ovarian cancer antigens
Locations: Immunitor LLC, Ulaanbaatar, Mongolia